Suchbegriffe: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK - , . Treffer: 3
Enzenhofer, E; Kadletz, L; Stanisz, I; Kotowski, U; Seemann, R; Schmid, R; Thurnher, D; Heiduschka, G
Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
Head Neck. 2017; 39(5):900-907
Doi: 10.1002/hed.24699
Web of Science
PubMed
FullText
FullText_MUG
Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D
Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Wien Klin Wochenschr. 2016; 128(9-10):320-328
Doi: 10.1007/s00508-016-0963-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M
Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690
Doi: 10.1016/j.humpath.2013.11.014
Web of Science
PubMed
FullText
FullText_MUG